VIR Vir Biotechnology, Inc.

NEUTRAL Impact: 2/10 Insider Cluster (2 insiders)
Horizon days Filed Jun 2, 2026 Processed 10d 10h ago
Insider cluster: 2 insiders, $34K total
Latest settled — T+1d
VIR ▲ +4.33% at T+1d
NEUTRAL call ✓ call won +4.33% · α vs SPY +3.93% · entry $8.77 → $9.15
Next anchor: T+5d due 4d ago
Currently $8.61 · -1.82% from $8.77 entry
Entry anchored
Jun 2, 2026
via day open
T+1d
+4.33%
call +4.33% · α +3.93%
$9.15
settled 10d ago
T+5d
call — · α —
due 4d ago
T+20d
call — · α —
in 18d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Two insiders at Vir Biotechnology sold a combined $34K in open-market sales on June 1, 2026, following a wave of non-cash director stock grants on May 27. The dollar amount is trivial relative to the $1.5B market cap (0.002%), and the sales are likely liquidity-driven rather than signaling bearish conviction. The cluster is not informative.

Key Financial Metrics

Direction
selling
Total Value
$33.8K
Insiders
2

Actionable Insight

Insider sales are negligible in size and follow routine director grants — no bearish signal. Monitor upcoming quarterly results for pipeline updates, as Vir's valuation is driven by clinical catalysts, not insider trading patterns.

Key Facts

  • Director Janet Napolitano sold 3,200 shares at $9.45 for $30,240 on June 1, 2026.
  • SVP/CAO Brent Sabatini sold 379 shares at $9.45 for $3,582 on June 1, 2026.
  • Total open-market sales: $33,822, representing ~0.002% of Vir's $1.5B market cap.
  • On May 27, 2026, six directors received non-cash stock grants totaling 128,000 shares (value $0).
  • Prior 30-day insider activity: only $34K in sales, consistent with routine patterns.

Financial Impact

Total insider sales of $34K are immaterial against $1.5B market cap.

insider holdings

Risk Factors

  • Insider sales, though small, could precede negative clinical data if insiders have material non-public information — but the dollar amount is too low to suggest this.
  • Historical calibration shows cluster reports on VIR have a 40% win rate at T+20, suggesting limited predictive power for this ticker.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-VIR-1780436144771
14 reports for VIR
Performance horizon
25% Hit rate 1 of 4 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
Type Now
Jun 10, 2026
2d ago
3
NEUTRAL ★ 1/10
$8.25 awaiting T+1awaiting T+1$8.61 (+4.36%)
Jun 10, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$8.25 awaiting T+1awaiting T+1$8.61 (+4.36%)
Jun 2, 2026
10d ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $9.15▲ +4.33%▲ +3.93%$8.61 (−1.82%)
May 28, 2026
15d ago
8-K
NEUTRAL ★ 2/10
$9.55 $9.54▼ −0.10%▼ −0.34%$8.61 (−9.84%)
Apr 16, 2026
8w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.75▲ +4.07%▲ +2.85%$8.61 (−16.65%)
Apr 10, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$9.31 $10.05▲ +7.95%▲ +6.74%$8.61 (−7.52%)
Apr 1, 2026
10w ago
Insider Cluster
BEARISH ★ 6/10
$9.02 $9.06▼ −0.44%▼ −0.36%$8.61 (+4.55%)
Mar 4, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$9.10 $9.55▲ +4.95%▲ +6.26%$8.61 (−5.38%)
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$9.49 $10.00▼ −5.37%▼ −4.54%$8.61 (+9.27%)
Feb 23, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$7.43 $9.49▼ −27.73%▼ −26.99%$8.61 (−15.88%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (53h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access